Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-029223

Chief Medical Officer sold 2,000 shares at $81.38 ($162,760)

  • Chief Medical Officer acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-08 Exercise or conversion : show line 1 in the form +2,000 $35.16 $70,320 2,881 D
2018-05-08 Sale : show line 2 in the form −2,000 $81.38 $162,760 881 D
Open-market sales · 2,000 sh · avg $81.38 · $162,760

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-08 Exercise or conversion : show line 3 in the form Stock option (right to buy) −2,000 99,000 D
Loading xslF345X03/doc4.xml…